Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Shares of Quest Diagnostics Inc. rallied 7.08% to $178.24 Tuesday, on what proved to be an all-around favorable trading ...

Quest Diagnostics Inc. (NYSE:DGX) delivered a robust second quarter in 2025, exceeding analyst expectations with strong sales ...

Quest Diagnostics Inc.’s DGX second-quarter 2025 adjusted earnings per share (EPS) of $2.62 beat the Zacks Consensus Estimate ...

Quest Diagnostics delivered better-than-expected Q2 earnings results, yet DGX stock stumbled, which opens a contrarian ...

Quest Diagnostics ranks first in Revenue Growth among its peers. It is second in Gross Profit and Return on Equity. The ...

Quest Diagnostics Inc. closed 8.75% short of its 52-week high of $182.38, which the company achieved on June 16th.

Shares of Quest Diagnostics Inc. DGX inched 0.90% higher to $132.82 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.56% ...

An appellate panel shut down a lawsuit from a compliance officer at Quest Diagnostics Inc. claiming the lab ran a fraudulent billing scheme for unnecessary tests.

Quest Diagnostics Inc. (NYSE: DGX) Q3 2023 Results Conference Call October 24, 2023 8:30 AM ET Company Participants Shawn Bevec - VP, IR Jim Davis - Chairman, President & CEO Sam Samad - CFO ...